Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2022-09-29
Product name:
LEO PHARMA - TACROLIMUS
DIN:
02531380
Product Monograph/Veterinary Labelling:
Date:
2022-09-28
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
LEO PHARMA GEN, A DIVISION OF LEO PHARMA INC.
6 Adelaide Street East, Suite 200
Toronto
Ontario
Canada
M5C 1H6
Class:
Human
Dosage form(s):
Ointment
Route(s) of administration:
Topical
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
84:06.28
Anatomical Therapeutic Chemical (ATC): See footnote 4
D11AH01 TACROLIMUS
Active ingredient group (AIG) number:See footnote5
0127857004
Active ingredient(s) See footnote8 | Strength |
---|---|
TACROLIMUS | 0.1 % / W/W |